STATIN-INDUCED EPIGENETIC DYSREGULATION CONTRIBUTES TO THE DEVELOPMENT OF TYPE 2 DIABETES MELLITUS

被引：0
作者：
Galicia, U. [1 ]
Jebari-Benslaiman, S. [1 ]
Larrea, A. [1 ]
Benito, A. [1 ,3 ,4 ]
Civeira, F. [2 ]
Cenarro, A. [5 ]
Martin, C. [1 ]
机构：
[1] Biofisika Inst, Biochem & Mol Biol, Leioa, Spain
[2] Unidad Lipidos & Arterioesclerosis, Lipid Unit, Zaragoza, Spain
[3] Hosp Univ Miguel Servet, CIBERCV, IIS Aragon, Zaragoza, Spain
[4] Univ Zaragoza, Dept Med, Zaragoza, Spain
[5] Hosp Univ Miguel Servet, IIS Aragon, Zaragoza, Spain
来源：
ATHEROSCLEROSIS | 2021年 / 331卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P520
引用
收藏
页码：E221 / E221
页数：1
相关论文
共 50 条
[31]   Apoptosis contributes to the generation of statin-induced myonecrosis in human skeletal muscle cells [J].
Ndountse-Tchapda, L ;
Schramm, U ;
Trommer, WE ;
Wolf, A .
DRUG METABOLISM REVIEWS, 2004, 36 :229-229
[32]   Statin therapy is associated with epigenetic modifications in individuals with type 2 diabetes [J].
Schrader, Silja ;
Perfilyev, Alexander ;
Martinell, Mats ;
Garcia-Calzon, Sonia ;
Ling, Charlotte .
EPIGENOMICS, 2021, 13 (12) :919-925
[33]   Statin-induced LDL cholesterol response and type 2 diabetes: a bidirectional two-sample Mendelian randomization study [J].
Smit, Roelof A. J. ;
Trompet, Stella ;
Leong, Aaron ;
Goodarzi, Mark O. ;
Postmus, Iris ;
Warren, Helen ;
Theusch, Elizabeth ;
Barnes, Michael R. ;
Arsenault, Benoit J. ;
Li, Xiaohui ;
Feng, QiPing ;
Chasman, Daniel, I ;
Cupples, L. Adrienne ;
Hitman, Graham A. ;
Krauss, Ronald M. ;
Psaty, Bruce M. ;
Rotter, Jerome, I ;
le Cessie, Saskia ;
Stein, C. Michael ;
Jukema, J. Wouter .
PHARMACOGENOMICS JOURNAL, 2020, 20 (03) :462-470
[34]   Statin-induced LDL cholesterol response and type 2 diabetes: a bidirectional two-sample Mendelian randomization study [J].
Roelof A. J. Smit ;
Stella Trompet ;
Aaron Leong ;
Mark O. Goodarzi ;
Iris Postmus ;
Helen Warren ;
Elizabeth Theusch ;
Michael R. Barnes ;
Benoit J. Arsenault ;
Xiaohui Li ;
QiPing Feng ;
Daniel I. Chasman ;
L. Adrienne Cupples ;
Graham A. Hitman ;
Ronald M. Krauss ;
Bruce M. Psaty ;
Jerome I. Rotter ;
Saskia le Cessie ;
C. Michael Stein ;
J. Wouter Jukema .
The Pharmacogenomics Journal, 2020, 20 :462-470
[35]   The metabolic-epigenetic nexus in type 2 diabetes mellitus [J].
Davison, Gareth W. ;
Irwin, Rachelle E. ;
Walsh, Colum P. .
FREE RADICAL BIOLOGY AND MEDICINE, 2021, 170 :194-206
[36]   Epigenetic Modifications Associated with the Pathogenesis of Type 2 Diabetes Mellitus [J].
Hossan, Tareq ;
Kundu, Shoumik ;
Alam, Sayeda Sadia ;
Nagarajan, Sankari .
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2019, 19 (06) :775-786
[37]   Current Genetic and Epigenetic Insights into Type 2 Diabetes Mellitus [J].
Alaml, Fahmida ;
Kamal, Mohammad A. ;
Islam, Md. Asiful ;
Banu, Shaheena .
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2019, 19 (06) :717-718
[38]   DNA Methylation: An Epigenetic Insight into Type 2 Diabetes Mellitus [J].
Alam, Fahmida ;
Islam, Md. Asiful ;
Gan, Siew Hua ;
Mohamed, Mafauzy ;
Sasongko, Teguh Haryo .
CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (28) :4398-4419
[39]   GENETICS Epigenetic mechanisms underlying type 2 diabetes mellitus [J].
Hanson, Mark A. ;
Godfrey, Keith M. .
Nature Reviews Endocrinology, 2015, 11 (05) :261-+
[40]   Epigenetic mechanisms in the development of type 2 diabetes [J].
Pinney, Sara E. ;
Simmons, Rebecca A. .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2010, 21 (04) :223-229
12345